Although infrequent, prostate cancers harbor BRAF mutations in around 2% of cases (Supplemental Fig. S7A)21,22, mostly involving hotspot mutations p.K601E and p.G469A (Supplemental Fig. S7B). Here, BRAF is linked to prostate cancer.